{"transactions":[{"id":4621300,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-09-17T20:22:42.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."}],"balance_after":605,"derivative":{"underlying":"Common Stock","underlying_shares":201},"source":{"system":"sec-edgar","filing":"0001228684-26-000010","document":"wk-form4_1789676560.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000010/wk-form4_1789676560.xml","form_type":"4"}},{"id":4621299,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:22:42.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":66,"price":80.01,"value":5280.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."}],"balance_after":94487,"source":{"system":"sec-edgar","filing":"0001228684-26-000010","document":"wk-form4_1789676560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000010/wk-form4_1789676560.xml","form_type":"4"}},{"id":4621298,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:22:42.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":759,"price":79,"value":59961.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $78.89 to $79.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":94553,"source":{"system":"sec-edgar","filing":"0001228684-26-000010","document":"wk-form4_1789676560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000010/wk-form4_1789676560.xml","form_type":"4"}},{"id":4621297,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:22:42.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":11675,"price":78.33,"value":914502.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $77.87 to $78.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":95312,"source":{"system":"sec-edgar","filing":"0001228684-26-000010","document":"wk-form4_1789676560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000010/wk-form4_1789676560.xml","form_type":"4"}},{"id":4621296,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:22:42.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":106987,"source":{"system":"sec-edgar","filing":"0001228684-26-000010","document":"wk-form4_1789676560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000010/wk-form4_1789676560.xml","form_type":"4"}},{"id":724135,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-29T20:30:42.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."}],"balance_after":806,"derivative":{"underlying":"Common Stock","underlying_shares":806},"source":{"system":"sec-edgar","filing":"0001228684-26-000008","document":"wk-form4_1782765039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000008/wk-form4_1782765039.xml","form_type":"4"}},{"id":724134,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-29T20:30:42.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":2417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2417,"derivative":{"underlying":"Common Stock","underlying_shares":2417},"source":{"system":"sec-edgar","filing":"0001228684-26-000008","document":"wk-form4_1782765039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000008/wk-form4_1782765039.xml","form_type":"4"}},{"id":724133,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-29T20:30:42.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":3837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3837,"derivative":{"exercise_price":64.34,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":3837},"source":{"system":"sec-edgar","filing":"0001228684-26-000008","document":"wk-form4_1782765039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000008/wk-form4_1782765039.xml","form_type":"4"}},{"id":732535,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:08:43.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":37037,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 17, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":74892,"source":{"system":"sec-edgar","filing":"0001193125-26-275841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526275841/ownership.xml","form_type":"4"}},{"id":734257,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:17:03.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1928,"price":62.94,"value":121348.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $62.68 to $63.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":106786,"source":{"system":"sec-edgar","filing":"0001228684-26-000006","document":"wk-form4_1781727420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000006/wk-form4_1781727420.xml","form_type":"4"}},{"id":734256,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:17:03.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":10572,"price":61.97,"value":655146.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $61.67 to $62.67. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":108714,"source":{"system":"sec-edgar","filing":"0001228684-26-000006","document":"wk-form4_1781727420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000006/wk-form4_1781727420.xml","form_type":"4"}},{"id":736353,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-16T20:06:28.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":2954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2954},"source":{"system":"sec-edgar","filing":"0001228684-26-000004","document":"wk-form4_1781640385.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000004/wk-form4_1781640385.xml","form_type":"4"}},{"id":736352,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:06:28.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":true,"shares":2954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":119286,"source":{"system":"sec-edgar","filing":"0001228684-26-000004","document":"wk-form4_1781640385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000004/wk-form4_1781640385.xml","form_type":"4"}},{"id":747707,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:30:14.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on June 3, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date, and will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company, or (c) the Reporting Person's death or disability. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":568062,"source":{"system":"sec-edgar","filing":"0001193125-26-259985","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000119312526259985/ownership.xml","form_type":"4"}},{"id":835127,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-18T20:11:18.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":493,"price":69.75,"value":34386.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $69.68 to $69.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":116332,"source":{"system":"sec-edgar","filing":"0001228684-26-000002","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000002/wk-form4_1773864674.xml","form_type":"4"}},{"id":835126,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-18T20:11:18.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":8378,"price":69.03,"value":578333.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $68.64 to $69.63. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":116825,"source":{"system":"sec-edgar","filing":"0001228684-26-000002","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000002/wk-form4_1773864674.xml","form_type":"4"}},{"id":835125,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-18T20:11:18.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":3629,"price":68.09,"value":247098.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $67.60 to $68.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":125203,"source":{"system":"sec-edgar","filing":"0001228684-26-000002","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868426000002/wk-form4_1773864674.xml","form_type":"4"}},{"id":965195,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:07:49.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":4766,"price":81.5,"value":388429.0,"ownership":{"direct":false,"nature":"By Link Family Enterprise, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sales were not effected by a sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.21 to $81.79. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001228684-25-000005","document":"wk-form4_1766005663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868425000005/wk-form4_1766005663.xml","form_type":"4"}},{"id":965194,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:07:49.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":5680,"price":80.71,"value":458432.8,"ownership":{"direct":false,"nature":"By Link Family Enterprise, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sales were not effected by a sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.21 to $81.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP."}],"balance_after":4766,"source":{"system":"sec-edgar","filing":"0001228684-25-000005","document":"wk-form4_1766005663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868425000005/wk-form4_1766005663.xml","form_type":"4"}},{"id":965193,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:07:49.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":1148,"price":82.39,"value":94583.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $82.23 to $82.92. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":128832,"source":{"system":"sec-edgar","filing":"0001228684-25-000005","document":"wk-form4_1766005663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868425000005/wk-form4_1766005663.xml","form_type":"4"}},{"id":965192,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:07:49.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":6306,"price":81.75,"value":515515.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.21 to $82.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129980,"source":{"system":"sec-edgar","filing":"0001228684-25-000005","document":"wk-form4_1766005663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868425000005/wk-form4_1766005663.xml","form_type":"4"}},{"id":965191,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:07:49.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":5046,"price":80.8,"value":407716.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.21 to $81.20. The Reporting Person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth in this footnote."}],"balance_after":136286,"source":{"system":"sec-edgar","filing":"0001228684-25-000005","document":"wk-form4_1766005663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868425000005/wk-form4_1766005663.xml","form_type":"4"}},{"id":1036398,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-18T21:00:33.000Z","date":"2025-09-16","kind":"gift","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":141332,"source":{"system":"sec-edgar","filing":"0001228684-25-000003","document":"wk-form4_1758229231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000122868425000003/wk-form4_1758229231.xml","form_type":"4"}},{"id":1044068,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-10T21:03:37.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":27116,"price":57,"value":1545612.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $56.66 to $57.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":143332,"source":{"system":"sec-edgar","filing":"0001819790-25-000113","document":"wk-form4_1757538213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000113/wk-form4_1757538213.xml","form_type":"4"}},{"id":1109880,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-16T20:03:22.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":false,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee\ndirector's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee\ndirector's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-25-000088","document":"wk-form4_1750104194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000088/wk-form4_1750104194.xml","form_type":"4"}},{"id":1109879,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-16T20:03:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":2954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2954,"derivative":{"underlying":"Common Stock","underlying_shares":2954},"source":{"system":"sec-edgar","filing":"0001819790-25-000088","document":"wk-form4_1750104194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000088/wk-form4_1750104194.xml","form_type":"4"}},{"id":1109878,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T20:03:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":4540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":4540,"derivative":{"exercise_price":40.95,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":4540},"source":{"system":"sec-edgar","filing":"0001819790-25-000088","document":"wk-form4_1750104194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000088/wk-form4_1750104194.xml","form_type":"4"}},{"id":1109877,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:03:22.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":true,"shares":3350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":170448,"source":{"system":"sec-edgar","filing":"0001819790-25-000088","document":"wk-form4_1750104194.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000088/wk-form4_1750104194.xml","form_type":"4"}},{"id":1123367,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T01:38:26.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10752,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":37855,"source":{"system":"sec-edgar","filing":"0000950170-25-081963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025081963/ownership.xml","form_type":"4"}},{"id":1131687,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-28T20:30:11.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":7374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 23, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date, and will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company, or (c) the Reporting Person's death or disability. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":550641,"source":{"system":"sec-edgar","filing":"0000950170-25-078370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000095017025078370/ownership.xml","form_type":"4"}},{"id":1433834,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:34:26.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":5021,"price":26.53,"value":133207.13,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.42 to $26.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-097097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000095017024097097/ownership.xml","form_type":"4"}},{"id":1433833,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:34:26.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":29979,"price":26.01,"value":779753.79,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.42 to $26.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":5021,"source":{"system":"sec-edgar","filing":"0000950170-24-097097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000095017024097097/ownership.xml","form_type":"4"}},{"id":1433832,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:34:26.000Z","date":"2024-08-12","kind":"other","planned":false,"acquired":true,"shares":27116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Partners XI, LLC to its partners."}],"balance_after":167098,"source":{"system":"sec-edgar","filing":"0000950170-24-097097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000095017024097097/ownership.xml","form_type":"4"}},{"id":1433831,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:34:26.000Z","date":"2024-08-12","kind":"other","planned":false,"acquired":true,"shares":10446,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Link Family Enterprise, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Partners XI, LLC to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP."}],"balance_after":10446,"source":{"system":"sec-edgar","filing":"0000950170-24-097097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000095017024097097/ownership.xml","form_type":"4"}},{"id":1433830,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:34:26.000Z","date":"2024-08-12","kind":"other","planned":false,"acquired":false,"shares":74892,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Partners XI, LLC to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000950170-24-097097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000095017024097097/ownership.xml","form_type":"4"}},{"id":1469604,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:25:30.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":false,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-24-000102","document":"wk-form4_1719354324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000102/wk-form4_1719354324.xml","form_type":"4"}},{"id":1469603,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T22:25:30.000Z","date":"2024-06-24","kind":"exercise","planned":false,"acquired":true,"shares":3350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":139982,"source":{"system":"sec-edgar","filing":"0001819790-24-000102","document":"wk-form4_1719354324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000102/wk-form4_1719354324.xml","form_type":"4"}},{"id":1479222,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-14T21:28:52.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3350,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-24-000073","document":"wk-form4_1718400524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000073/wk-form4_1718400524.xml","form_type":"4"}},{"id":1479221,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T21:28:52.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":5000,"derivative":{"exercise_price":33.14,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001819790-24-000073","document":"wk-form4_1718400524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000073/wk-form4_1718400524.xml","form_type":"4"}},{"id":1485369,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:17:58.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":2554,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":27103,"source":{"system":"sec-edgar","filing":"0000950170-24-071313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024071313/ownership.xml","form_type":"4"}},{"id":1521964,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-09T20:30:39.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in\nfull on May 7, 2025, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with\nthe Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":543267,"source":{"system":"sec-edgar","filing":"0000950170-24-057102","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000095017024057102/ownership.xml","form_type":"4"}},{"id":1662281,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T21:49:26.000Z","date":"2024-02-01","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Link Family Enterprise, L.P. The Reporting Person is a managing partner of Link Family Enterprise, L.P. and may be deemed to share voting and investment power over the securities held by Link Family Enterprise, L.P. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":21248,"source":{"system":"sec-edgar","filing":"0000950170-24-010569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024010569/ownership.xml","form_type":"4"}},{"id":1662280,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T21:49:26.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":7652,"price":50.0084,"value":382664.2768,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 7,652 shares sold in the price range of $49.91 to $50.17 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Link Family Enterprise, L.P. The Reporting Person is a managing partner of Link Family Enterprise, L.P. and may be deemed to share voting and investment power over the securities held by Link Family Enterprise, L.P. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":24248,"source":{"system":"sec-edgar","filing":"0000950170-24-010569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024010569/ownership.xml","form_type":"4"}},{"id":1662279,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T21:49:26.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":20598,"price":49.5415,"value":1020455.817,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 20,598 shares sold in the price range of $48.91 to $49.90 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Link Family Enterprise, L.P. The Reporting Person is a managing partner of Link Family Enterprise, L.P. and may be deemed to share voting and investment power over the securities held by Link Family Enterprise, L.P. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":31900,"source":{"system":"sec-edgar","filing":"0000950170-24-010569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024010569/ownership.xml","form_type":"4"}},{"id":1802198,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T22:46:17.000Z","date":"2023-08-17","kind":"other","planned":false,"acquired":true,"shares":21248,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Flying L Partners, II LLC on a pro rata basis based upon each such member's respective capital interests in Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Link Family Enterprise, L.P. The Reporting Person is a managing partner of Link Family Enterprise, L.P. and may be deemed to share voting and investment power over the securities held by Link Family Enterprise, L.P. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":52498,"source":{"system":"sec-edgar","filing":"0001209191-23-046645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123046645/doc4.xml","form_type":"4"}},{"id":1802197,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T22:46:17.000Z","date":"2023-08-17","kind":"other","planned":false,"acquired":true,"shares":2610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Flying L Partners, II LLC on a pro rata basis based upon each such member's respective capital interests in Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC."}],"balance_after":24549,"source":{"system":"sec-edgar","filing":"0001209191-23-046645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123046645/doc4.xml","form_type":"4"}},{"id":1802196,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T22:46:17.000Z","date":"2023-08-17","kind":"other","planned":false,"acquired":false,"shares":694124,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Flying L Partners, II LLC on a pro rata basis based upon each such member's respective capital interests in Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-046645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123046645/doc4.xml","form_type":"4"}},{"id":1844316,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-26T21:47:09.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3350,"derivative":{"underlying":"Common Stock","underlying_shares":3350},"source":{"system":"sec-edgar","filing":"0001819790-23-000054","document":"wk-form4_1687816019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000054/wk-form4_1687816019.xml","form_type":"4"}},{"id":1844315,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T21:47:09.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":5000,"derivative":{"exercise_price":17.99,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001819790-23-000054","document":"wk-form4_1687816019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000054/wk-form4_1687816019.xml","form_type":"4"}},{"id":1847978,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-21T22:08:51.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001819790-23-000041","document":"wk-form4_1687385320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000041/wk-form4_1687385320.xml","form_type":"4"}},{"id":1847977,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T22:08:51.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":136632,"source":{"system":"sec-edgar","filing":"0001819790-23-000041","document":"wk-form4_1687385320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000041/wk-form4_1687385320.xml","form_type":"4"}},{"id":1867703,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:32:11.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":21939,"source":{"system":"sec-edgar","filing":"0001209191-23-034325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123034325/doc4.xml","form_type":"4"}},{"id":1874509,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T21:00:08.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":33175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":33175,"derivative":{"exercise_price":3.23,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":33175},"source":{"system":"sec-edgar","filing":"0000899243-23-014076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000089924323014076/doc4.xml","form_type":"4"}},{"id":1874508,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T21:00:08.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":9288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2024, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":521267,"source":{"system":"sec-edgar","filing":"0000899243-23-014076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000089924323014076/doc4.xml","form_type":"4"}},{"id":1893683,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T21:57:25.000Z","date":"2023-05-11","kind":"other","planned":true,"acquired":true,"shares":41219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the receipt of shares from a pro-rata in-kind distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":109892,"source":{"system":"sec-edgar","filing":"0001209191-23-029596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123029596/doc4.xml","form_type":"4"}},{"id":1893682,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T21:57:25.000Z","date":"2023-05-11","kind":"other","planned":true,"acquired":false,"shares":215576,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Investments XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC on May 19, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Investments XI, LLC.  The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-029596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123029596/doc4.xml","form_type":"4"}},{"id":1895428,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T19:15:11.000Z","date":"2023-05-11","kind":"other","planned":false,"acquired":true,"shares":98715,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":694124,"source":{"system":"sec-edgar","filing":"0001209191-23-028948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123028948/doc4.xml","form_type":"4"}},{"id":1895427,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T19:15:11.000Z","date":"2023-05-11","kind":"other","planned":false,"acquired":false,"shares":258390,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by RxSight I. The Reporting Person is a managing member of RxSight I and may be deemed to share voting and investment power over the securities held by RxSight I. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-028948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123028948/doc4.xml","form_type":"4"}},{"id":1947346,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T22:39:00.000Z","date":"2023-03-15","kind":"other","acquired":true,"shares":52194,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the receipt of shares from a pro-rata in-kind distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":68673,"source":{"system":"sec-edgar","filing":"0001209191-23-019891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019891/doc4.xml","form_type":"4"}},{"id":1947345,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T22:39:00.000Z","date":"2023-03-15","kind":"other","acquired":false,"shares":215575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Investments XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Investments XI, LLC.  The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":215576,"source":{"system":"sec-edgar","filing":"0001209191-23-019891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019891/doc4.xml","form_type":"4"}},{"id":2118156,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-14T21:34:30.000Z","date":"2022-11-10","kind":"other","acquired":true,"shares":8382,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the receipt of shares from a pro-rata in-kind distribution and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":16479,"source":{"system":"sec-edgar","filing":"0001209191-22-056627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919122056627/doc4.xml","form_type":"4"}},{"id":2118155,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-14T21:34:30.000Z","date":"2022-11-10","kind":"other","acquired":false,"shares":215575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Investments XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Investments XI, LLC.  The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":431151,"source":{"system":"sec-edgar","filing":"0001209191-22-056627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919122056627/doc4.xml","form_type":"4"}},{"id":2118482,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-14T21:05:28.000Z","date":"2022-11-09","kind":"other","acquired":true,"shares":107236,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":595409,"source":{"system":"sec-edgar","filing":"0001209191-22-056565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122056565/doc4.xml","form_type":"4"}},{"id":2118481,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-14T21:05:28.000Z","date":"2022-11-09","kind":"other","acquired":false,"shares":316694,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by RxSight I. The Reporting Person is a managing member of RxSight I and may be deemed to share voting and investment power over the securities held by RxSight I. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":258390,"source":{"system":"sec-edgar","filing":"0001209191-22-056565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122056565/doc4.xml","form_type":"4"}},{"id":2182011,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:22:04.000Z","date":"2022-08-15","kind":"other","acquired":true,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the receipt of shares from a pro-rata in-kind distribution and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":8097,"source":{"system":"sec-edgar","filing":"0001209191-22-046254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919122046254/doc4.xml","form_type":"4"}},{"id":2182010,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:22:04.000Z","date":"2022-08-15","kind":"other","acquired":false,"shares":215575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Investments XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Investments XI, LLC.  The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":646726,"source":{"system":"sec-edgar","filing":"0001209191-22-046254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919122046254/doc4.xml","form_type":"4"}},{"id":2188361,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:47:31.000Z","date":"2022-08-10","kind":"other","acquired":true,"shares":107236,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":488173,"source":{"system":"sec-edgar","filing":"0001209191-22-045434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122045434/doc4.xml","form_type":"4"}},{"id":2188360,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:47:31.000Z","date":"2022-08-10","kind":"other","acquired":false,"shares":316694,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by RxSight I. The Reporting Person is a managing member of RxSight I and may be deemed to share voting and investment power over the securities held by RxSight I. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":575084,"source":{"system":"sec-edgar","filing":"0001209191-22-045434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122045434/doc4.xml","form_type":"4"}},{"id":2217435,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-01T16:28:21.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2000,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001628280-22-018345","document":"wf-form4_165669288165617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022018345/wf-form4_165669288165617.xml","form_type":"4"}},{"id":2217434,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:28:21.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":7000,"derivative":{"exercise_price":12.89,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001628280-22-018345","document":"wf-form4_165669288165617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000162828022018345/wf-form4_165669288165617.xml","form_type":"4"}},{"id":2238086,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T22:22:07.000Z","date":"2022-06-08","kind":"other","acquired":true,"shares":126979,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":380937,"source":{"system":"sec-edgar","filing":"0001209191-22-035584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122035584/doc4.xml","form_type":"4"}},{"id":2238085,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T22:22:07.000Z","date":"2022-06-08","kind":"other","acquired":false,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock  to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by RxSight I. The Reporting Person is a managing member of RxSight I and may be deemed to share voting and investment power over the securities held by RxSight I. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":891778,"source":{"system":"sec-edgar","filing":"0001209191-22-035584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122035584/doc4.xml","form_type":"4"}},{"id":2239291,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T20:07:42.000Z","date":"2022-05-17","kind":"other","acquired":true,"shares":126979,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being filed to report the acquisition of shares by Flying L Partners, II LLC, of which the Reporting Person is a managing member, and the Reporting Person's direct holdings, each inadvertently omitted from the Form 4 filed May 19, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":253958,"source":{"system":"sec-edgar","filing":"0001209191-22-035013","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122035013/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-19"}},{"id":2239290,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T20:04:00.000Z","date":"2022-03-15","kind":"other","acquired":true,"shares":126979,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being filed to report the acquisition of shares by Flying L Partners, II LLC, of which the Reporting Person is a managing member, and the Reporting Person's direct holdings, each inadvertently omitted from the Form 4 filed March 17, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a distribution not for value of shares of the Issuer's Common Stock to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Flying L Partners, II LLC. The Reporting Person is a managing member of Flying L Partners, II LLC and may be deemed to share voting and investment power over the securities held by Flying L Partners, II LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":126979,"source":{"system":"sec-edgar","filing":"0001209191-22-034997","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122034997/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-17"}},{"id":2245523,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-04T00:21:53.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":10349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant.  \"Date of Grant\" shall mean June 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":47458,"source":{"system":"sec-edgar","filing":"0001209191-22-034391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122034391/doc4.xml","form_type":"4"}},{"id":2251077,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T15:44:21.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.  The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":15616,"derivative":{"exercise_price":7,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15616},"source":{"system":"sec-edgar","filing":"0000899243-22-020097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000089924322020097/doc4.xml","form_type":"4"}},{"id":2251076,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T15:44:21.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":4285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date.  The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":511979,"source":{"system":"sec-edgar","filing":"0000899243-22-020097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000089924322020097/doc4.xml","form_type":"4"}},{"id":2264225,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T20:06:09.000Z","date":"2022-05-17","kind":"other","acquired":false,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock (\"Common Stock\") to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock (\"IPO\"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock (\"Common Stock\") to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock (\"IPO\"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO."}],"balance_after":1266778,"source":{"system":"sec-edgar","filing":"0000899243-22-018791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924322018791/doc4.xml","form_type":"4"}},{"id":2328397,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-18T01:13:34.000Z","date":"2022-03-15","kind":"other","acquired":false,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock (\"Common Stock\") to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock (\"IPO\"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock (\"Common Stock\") to the members of RxSight I, LLC (\"RxSight I\") on a pro rata basis based upon each such member's respective capital interests in RxSight I. The Reporting Person is a managing member of RxSight I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects Common Stock held by the Reporting Person. The Reporting Person obtained the Common Stock in connection with the initial public offering of the Common Stock (\"IPO\"), pursuant to which shares of the Issuer's Series H Preferred Stock, par value $0.001 per share, held by the Reporting Persons were automatically converted on a one-for-one basis to shares of Common Stock prior to the closing of the IPO."}],"balance_after":1641778,"source":{"system":"sec-edgar","filing":"0000899243-22-011520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924322011520/doc4.xml","form_type":"4"}},{"id":2439876,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T23:08:51.000Z","date":"2022-01-05","kind":"other","acquired":true,"shares":401,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to The Link Family Trust, dated May 19, 2005, without consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by The Link Family Trust. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the Trustee of The Link Family Trust."}],"balance_after":2074,"source":{"system":"sec-edgar","filing":"0001209191-22-002535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919122002535/doc4.xml","form_type":"4"}},{"id":2439875,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T23:08:51.000Z","date":"2022-01-05","kind":"other","acquired":true,"shares":6438,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. (\"Capital IV\") to Versant Ventures IV, LLC (\"Ventures IV\"), its sole general partner, without consideration, and from Ventures IV to Link Family Enterprise, LP as a member of Ventures IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Link Family Enterprise, LP. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP."}],"balance_after":33480,"source":{"system":"sec-edgar","filing":"0001209191-22-002535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919122002535/doc4.xml","form_type":"4"}},{"id":2459443,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T22:34:59.000Z","date":"2021-12-21","kind":"other","acquired":true,"shares":400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to The Link Family Trust, dated May 19, 2005, without consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by The Link Family Trust. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the Trustee of The Link Family Trust."}],"balance_after":1673,"source":{"system":"sec-edgar","filing":"0001209191-21-071128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121071128/doc4.xml","form_type":"4"}},{"id":2459442,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T22:34:59.000Z","date":"2021-12-21","kind":"other","acquired":true,"shares":6438,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. (\"Capital IV\") to Versant Ventures IV, LLC (\"Ventures IV\"), its sole general partner, without consideration, and from Ventures IV to Link Family Enterprise, LP as a member of Ventures IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Link Family Enterprise, LP. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP."}],"balance_after":27042,"source":{"system":"sec-edgar","filing":"0001209191-21-071128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121071128/doc4.xml","form_type":"4"}},{"id":2510934,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T00:58:27.000Z","date":"2021-11-11","kind":"other","acquired":true,"shares":4348,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Partners XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the receipt of shares from a pro-rata in-kind distribution and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":4348,"source":{"system":"sec-edgar","filing":"0001209191-21-064905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121064905/doc4.xml","form_type":"4"}},{"id":2510933,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T00:58:27.000Z","date":"2021-11-11","kind":"other","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Flying L Investments XI, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly held by Flying L Investments XI, LLC.  The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein."}],"balance_after":862301,"source":{"system":"sec-edgar","filing":"0001209191-21-064905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121064905/doc4.xml","form_type":"4"}},{"id":2538067,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T20:32:01.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1531,"price":15.0939,"value":23108.7609,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Side Fund IV. The Reporting Person may be deemed to beneficially own the shares held by Versant Side Fund IV as a managing member of Versant Ventures IV, its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Versant Side Fund IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":4987,"source":{"system":"sec-edgar","filing":"0001209191-21-061153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121061153/doc4.xml","form_type":"4"}},{"id":2538066,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T20:32:01.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1912,"price":14.6327,"value":27977.7224,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $14.00 to $14.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Side Fund IV. The Reporting Person may be deemed to beneficially own the shares held by Versant Side Fund IV as a managing member of Versant Ventures IV, its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Versant Side Fund IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":6518,"source":{"system":"sec-edgar","filing":"0001209191-21-061153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121061153/doc4.xml","form_type":"4"}},{"id":2538065,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T20:32:01.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":242943,"price":15.0939,"value":3666957.3477,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant IV. The Reporting Person may be deemed to beneficially own the shares held by Versant IV as a managing member of Versant Ventures IV, LLC (\"Versant Ventures IV\"), its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Versant IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":815033,"source":{"system":"sec-edgar","filing":"0001209191-21-061153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121061153/doc4.xml","form_type":"4"}},{"id":2538064,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T20:32:01.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":303614,"price":14.6327,"value":4442692.5778,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $14.00 to $14.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant IV. The Reporting Person may be deemed to beneficially own the shares held by Versant IV as a managing member of Versant Ventures IV, LLC (\"Versant Ventures IV\"), its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Versant IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1057976,"source":{"system":"sec-edgar","filing":"0001209191-21-061153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121061153/doc4.xml","form_type":"4"}},{"id":2613326,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series H Preferred Stock","published_at":"2021-08-05T23:34:44.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":2016778,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by RxSight I, LLC. The Reporting Person is a managing member of RxSight I, LLC and may be deemed to share voting and investment power over the securities held by RxSight I, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2016778},"source":{"system":"sec-edgar","filing":"0000899243-21-031822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031822/doc4.xml","form_type":"4"}},{"id":2613325,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:34:44.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":31250,"price":16,"value":500000.0,"ownership":{"direct":true},"balance_after":37109,"source":{"system":"sec-edgar","filing":"0000899243-21-031822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031822/doc4.xml","form_type":"4"}},{"id":2613324,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:34:44.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":2016778,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by RxSight I, LLC. The Reporting Person is a managing member of RxSight I, LLC and may be deemed to share voting and investment power over the securities held by RxSight I, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein."}],"balance_after":2016778,"source":{"system":"sec-edgar","filing":"0000899243-21-031822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031822/doc4.xml","form_type":"4"}},{"id":2620297,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T00:15:00.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":5859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock"},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the date immediately prior to the first annual meeting of stockholders following July 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock"}],"balance_after":5859,"source":{"system":"sec-edgar","filing":"0000899243-21-031106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031106/doc4.xml","form_type":"4"}},{"id":2664122,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:25:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The option is fully vested."}],"balance_after":10000,"derivative":{"exercise_price":35.26,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-041712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121041712/doc4.xml","form_type":"4"}},{"id":2664121,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:25:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":10000,"derivative":{"exercise_price":35.26,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-041712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121041712/doc4.xml","form_type":"4"}},{"id":2675367,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T00:44:34.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":5199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares underlying the option vest as to one-twelfth (1/12th) of the shares on July 7, 2021 and monthly thereafter on the same day of the month as the grant date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date."}],"balance_after":5199,"derivative":{"exercise_price":17.74,"expiration_date":"2031-06-06","underlying":"Common Stock","underlying_shares":5199},"source":{"system":"sec-edgar","filing":"0001209191-21-039332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121039332/doc4.xml","form_type":"4"}},{"id":2675366,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-10T00:44:34.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU will vest on June 7, 2022, but will vest fully on the date of the next annual stockholder meeting held after the date of grant if not fully vested on such date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001209191-21-039332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121039332/doc4.xml","form_type":"4"}},{"id":2679044,"issuer":{"id":3510,"kind":"organization","name":"GLAUKOS Corp","symbol":"GKOS"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T23:05:31.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":2382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,382 restricted stock units that have not yet vested or been delivered to the Reporting Person."}],"balance_after":17821,"source":{"system":"sec-edgar","filing":"0001104659-21-077839","document":"tm2119039-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000110465921077839/tm2119039-6_4seq1.xml","form_type":"4"}},{"id":2702768,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T20:15:35.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":20847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":20847,"derivative":{"exercise_price":7.49,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":20847},"source":{"system":"sec-edgar","filing":"0000899243-21-020140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000089924321020140/doc4.xml","form_type":"4"}},{"id":2712072,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":34847,"kind":"person","name":"LINK WILLIAM J PHD","position":1,"cik":"0001228684","reported_name":"LINK WILLIAM J PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T20:42:34.000Z","date":"2021-05-12","kind":"other","acquired":true,"shares":642,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to The Link Family Trust, dated May 19, 2005, without consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by The Link Family Trust. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the Trustee of The Link Family Trust."}],"balance_after":1273,"source":{"system":"sec-edgar","filing":"0001209191-21-032758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228684/000120919121032758/doc4.xml","form_type":"4"}}],"next_cursor":"2021-05-14T20:42:34.000000Z,2712072"}